JP2010521978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521978A5 JP2010521978A5 JP2009554792A JP2009554792A JP2010521978A5 JP 2010521978 A5 JP2010521978 A5 JP 2010521978A5 JP 2009554792 A JP2009554792 A JP 2009554792A JP 2009554792 A JP2009554792 A JP 2009554792A JP 2010521978 A5 JP2010521978 A5 JP 2010521978A5
- Authority
- JP
- Japan
- Prior art keywords
- riboswitch
- preq
- compound
- cell
- responsive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108020004422 Riboswitch Proteins 0.000 claims description 155
- 230000014509 gene expression Effects 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 55
- 150000001875 compounds Chemical class 0.000 claims description 52
- 230000001580 bacterial effect Effects 0.000 claims description 49
- 108091023037 Aptamer Proteins 0.000 claims description 43
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 36
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 23
- 230000035772 mutation Effects 0.000 claims description 21
- 230000005764 inhibitory process Effects 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 8
- 230000009146 cooperative binding Effects 0.000 claims description 7
- 208000035143 Bacterial infection Diseases 0.000 claims description 6
- 108091026890 Coding region Proteins 0.000 claims description 6
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 6
- 230000010261 cell growth Effects 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 230000002269 spontaneous effect Effects 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 108700026244 Open Reading Frames Proteins 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 5
- 108091035707 Consensus sequence Proteins 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- 230000008848 allosteric regulation Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008846 dynamic interplay Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91941007P | 2007-03-22 | 2007-03-22 | |
| PCT/US2008/058050 WO2008116223A1 (en) | 2007-03-22 | 2008-03-24 | Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521978A JP2010521978A (ja) | 2010-07-01 |
| JP2010521978A5 true JP2010521978A5 (enExample) | 2011-04-28 |
Family
ID=39766517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009554792A Withdrawn JP2010521978A (ja) | 2007-03-22 | 2008-03-24 | Ｐｒｅｑ１リボスイッチならびにｐｒｅｑ１リボスイッチの使用のための、およびｐｒｅｑ１リボスイッチを用いる使用のための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20100152212A1 (enExample) |
| EP (1) | EP2139909A4 (enExample) |
| JP (1) | JP2010521978A (enExample) |
| WO (1) | WO2008116223A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120122819A1 (en) | 2009-06-12 | 2012-05-17 | Socpra - Sciences Et Genie S.E.C. | Guanine riboswitch binding compounds and their use as antibiotics |
| GB201107768D0 (en) * | 2011-05-10 | 2011-06-22 | Univ Manchester | Riboswitches |
| US10093967B2 (en) * | 2014-08-12 | 2018-10-09 | The Regents Of The University Of Michigan | Detection of nucleic acids |
| US11267842B2 (en) | 2015-03-03 | 2022-03-08 | The Regents Of The University Of California | Enzymatic modification of nucleic acids |
| US20180073026A1 (en) * | 2015-04-01 | 2018-03-15 | Universität Wien | Novel expression regulating rna-molecules and uses thereof |
| CA3055565A1 (en) | 2017-03-08 | 2018-09-13 | The Regents Of The University Of Michigan | Analyte detection |
| CN110650624A (zh) | 2017-03-10 | 2020-01-03 | 威斯康星州医药大学股份有限公司 | 用于视网膜疾病的核糖开关调节的基因治疗 |
| WO2018226666A1 (en) * | 2017-06-05 | 2018-12-13 | Maumita Mandal | Methods, compositions, and devices involving pseudoknot formation |
| GB202011812D0 (en) * | 2020-07-29 | 2020-09-09 | Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid | Compounds |
| CA3193099A1 (en) * | 2020-09-24 | 2022-03-31 | David R. Liu | Prime editing guide rnas, compositions thereof, and methods of using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003288906C1 (en) * | 2002-09-20 | 2010-12-09 | Yale University | Riboswitches, methods for their use, and compositions for use with riboswitches. |
-
2008
- 2008-03-24 US US12/532,538 patent/US20100152212A1/en not_active Abandoned
- 2008-03-24 EP EP08799599A patent/EP2139909A4/en not_active Withdrawn
- 2008-03-24 JP JP2009554792A patent/JP2010521978A/ja not_active Withdrawn
- 2008-03-24 WO PCT/US2008/058050 patent/WO2008116223A1/en not_active Ceased
-
2012
- 2012-09-14 US US13/617,993 patent/US20130012527A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521978A5 (enExample) | ||
| JP2010528617A5 (ja) | リボスイッチならびにリボスイッチを使用するためのおよびリボスイッチと共に使用するための方法および組成物 | |
| Nordmann et al. | A new splice variant of the human guanylate‐binding protein 3 mediates anti‐influenza activity through inhibition of viral transcription and replication | |
| Jia et al. | WHEP domains direct noncanonical function of glutamyl-Prolyl tRNA synthetase in translational control of gene expression | |
| JP2023516974A (ja) | ＶＩ－Ｅ型及びＶＩ－Ｆ型ＣＲＩＳＰＲ－Ｃａｓシステム並びにそれらの使用 | |
| Amara et al. | TGF-β1, regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization | |
| Li et al. | Runx2 contributes to murine Col10a1 gene regulation through direct interaction with its cis‐enhancer | |
| US20170247762A1 (en) | Compositions, methods and use of synthetic lethal screening | |
| JP2021006047A (ja) | 機能性核酸分子、及びその利用 | |
| Schusser et al. | Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus | |
| US11377658B2 (en) | Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases | |
| CN1854313A (zh) | 非小细胞肺癌的诊断方法 | |
| JP2010521978A (ja) | Ｐｒｅｑ１リボスイッチならびにｐｒｅｑ１リボスイッチの使用のための、およびｐｒｅｑ１リボスイッチを用いる使用のための方法および組成物 | |
| Lossie et al. | Molecular mechanism regulating myosin and cardiac functions by ELC | |
| KR102695765B1 (ko) | 타우 시딩 또는 응집의 유전적 변형제를 식별하기 위한 CRISPR/Cas 스크리닝 플랫폼 | |
| US20110294872A1 (en) | High-affinity nucleic acid aptamers against sclerostin protein | |
| JP2022526297A (ja) | タウ凝集に関連する遺伝的脆弱性を明らかにするためのｃｒｉｓｐｒ／ｃａｓドロップアウトスクリーニングプラットフォーム | |
| WO2003000861A3 (en) | Eukaryotic genes involved in adult lifespan regulation | |
| JP2006524491A5 (enExample) | ||
| JP6618079B2 (ja) | エクソソーム産生促進剤 | |
| Sanecka et al. | Analysis of genes regulated by the transcription factor LUMAN identifies ApoA4 as a target gene in dendritic cells | |
| CN105755027B (zh) | 一种基于miRNA137调节DAT基因表达的方法 | |
| JP2008515436A (ja) | グリシン・リボスイッチ、それを使用する方法、及びグリシン・リボスイッチを用いた使用のための組成物 | |
| US20220098682A1 (en) | Enhanced cell based screening platform for anti-hbv therapeutics | |
| JP2012023998A (ja) | 真核細胞における目的遺伝子の発現制御方法、ｒｎａ分子およびｄｎａ分子 |